Microsize is the largest independent Contract Development and Manufacturing Organisation (CDMO) in the United States, specialising in solubility enhancement and particle size reduction for the pharmaceutical industry. With over 30 years of experience, Microsize provides comprehensive services from small-scale, pre-clinical development to full-scale cGMP commercial manufacturing. The company focuses significantly on the drug substance (DS) to drug product (DP) interface, delivering tailored solutions for a wide range of applications.

Services include:
– Small Molecule, Drug Substance Manufacturing (API)
– Drug Product Formulation (FDF)
– Research & Development
– Analytical Methods Development
– Micronization
– Miling Technology Customisation
– Tech Transfer and Scale-Up
– Quality Assurance and Control Systems

Microsize possesses the expertise and domain knowledge necessary to optimise processes to meet critical quality attributes and material attributes, ensuring that their solutions are appropriate for various projects and campaigns. For more information, please visit microsize.com.